Previous 10 | Next 10 |
2023-03-16 09:33:00 ET When searching for penny stocks to buy or penny stocks to watch, it’s good to focus on catalysts. Typically valued under $5 per share, these stocks generally attract small and new investors. Even with the glitz and glamour that comes with massive breakouts,...
Inhibikase Therapeutics to Host Virtual R&D Event on March 22, 2023 Inhibikase Therapeutics to Host Virtual R&D Event on March 22, 2023 PR Newswire BOSTON and ATLANTA , March 16, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT...
2023-03-08 09:07:24 ET Nano-cap biotech Inhibikase Therapeutics ( NASDAQ: IKT ) added ~35% pre-market Wednesday after announcing that the FDA lifted the full clinical hold on its lead candidate IkT-148009 targeted at neurological disorder multiple system atrophy (MSA). ...
Inhibikase Therapeutics Announces FDA has Lifted the Full Clinical Hold on IkT-148009 in Multiple System Atrophy PR Newswire - Advancing model studies of IkT-148009 in MSA; early data has shown a substantial neuroprotective benefit in response to c-Abl inhibition by IkT-148009...
Inhibikase Therapeutics to Present at the 11th Annual Alzheimer's & Parkinson's Drug Development Summit Inhibikase Therapeutics to Present at the 11th Annual Alzheimer's & Parkinson's Drug Development Summit PR Newswire BOSTON and ATLANTA , Feb. 15, 2023 ...
Inhibikase Therapeutics Announces Closing of $10 Million Concurrent Registered Direct Offering and Private Placement Priced At a Premium to Market Under Nasdaq Rules PR Newswire BOSTON and ATLANTA , Jan. 27, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Jeff Whyte / Shutterstock.com Chevron (NYSE: CVX ) stock is on the rise Thursday following a new share buyback program and dividend for investors. That new share buyback program has a total value of $75 b...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Carlos E. Santa Maria / Shutterstock.com Southwest Airlines (NYSE: LUV ) stock is falling on Thursday following the release of its latest earnings report. The big news hitting LUV stock today is an $800 m...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Inhibikase Therapeutics (NASDAQ: IKT ) stock is falling on Thursday after the company announced a registered direct offering and private placement . Starting with the registered direct offeri...
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering and Private Placement Priced at a Premium to Market Under Nasdaq Rules PR Newswire BOSTON and ATLANTA , Jan. 25, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IK...
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...